Skip to main content

Lung Cancer Treatment

The most commonly used treatments for lung cancer are surgery, chemotherapy and radiation. The exact treatment a lung cancer patient receives will depend on several factors. These include the type of cancer, the stage or extent to which it has spread at the time of diagnosis, and the overall health of the patient.

Non-small cell lung cancer, which accounts for about 80 percent of lung cancer cases, is treated depending on its stage at diagnosis. Lung surgery is the mainstay of treatment for the early stages of lung cancer. Cancerous tissue, along with a margin of healthy tissue, is removed. Patients who are unable to have surgery may be treated with radiotherapy. While cure rates for early lung cancer are good, it is rarely detected in its early stages. As non-small cell cancer spreads within the chest, it is treated with some combination of surgery, chemotherapy and radiotherapy. Once cancer has spread to other parts of the body, chemotherapy and radiotherapy replace surgery as the main treatment options. A number of drugs are available, and many more are being tested in clinical trials. Radiotherapy is palliative, and while it may ease symptoms such as pain and cough, it will not stop cancer growth. If the cancer obstructs a major airway, using a laser, freezing the tumor or keeping the airway open with a stent or tube may remove the obstruction.

Small cell lung cancer, which is found in about 20 percent of lung cancer patients, is more aggressive and more likely to have spread by the time of diagnosis. It is therefore treated primarily with chemotherapy. Radiotherapy to the chest may also be used to kill off remaining cancer cells. This type of cancer often spreads to the brain. This is why radiotherapy to the brain may be used as a prophylactic even if no cancer is detected in the brain.

Popular posts from this blog

Lung cancer survival rate - Stage 2 lung cancer

When a person looks for a medical professional about the stage 2 lung cancer, one of the first questions that come to mind is: what is my lung cancer survival rate? This is largely influenced by the medical records showing that lung cancer is one of the lowest chances of survival of cancers in the world. One must realize that these statistics are only numbers and a variety of factors that can affect your chances of being cured. The lung cancer survival rate is affected by several variables. One such variable is age. Younger people tend to have a greater chance of survival for people over 50. This is due to the strong natural defenses younger than the older. Medical records also indicate that women with lung cancer in stage 2 have a greater ability to be cured of their male counterparts the parties. The spread of malignant tumor is a very important factor in determining the survival of lung cancer exchange rate. The tumors may spread from the lung tissu...

Analysis: Life saving lung cancer test to set off cost debate

By Bill Berkrot NEW YORK | Wed Jun 29, 2011 6:07pm EDT NEW YORK (Reuters) - A landmark study showing that routine lung screening of heavy smokers and former smokers using low dose CT scans could save thousands of lives is sure to set off a fierce debate about the cost of such testing on an overburdened healthcare system. The U.S. National Cancer Institute studied more than 53,000 people between the ages of 55 and 74 deemed at high risk of developing lung cancer. It found that screening with the three-dimensional X-rays cut deaths by 20 percent. Details of the study and a discussion of its implications were published on Wednesday in the New England Journal of Medicine, lending additional weight to initial findings that were released in November. The discussion noted that radiologists using more advanced CT equipment than was available for the study could lead to an even larger reduction in lung cancer deaths. At the same time, the potential for many more false positive results could ri...

Alternative Pain Therapy for Breast, Prostate and Lung Cancer

Alternative Pain Therapy for Breast, Prostate and Lung Cancer MIAMI--(Healthcare Sales & Marketing Network)-- Bio-Nucleonics? lead product Strontium Chloride Sr-89 Injection USP (Strontium-89), which is the generic version of Metastron?, is an option to consider for metastatic cancer bone pain therapy, typically caused by advanced stage breast, prostate or lung cancer. Strontium Chloride Sr-89 Injection USP (Strontium-89) is a radioactive pharmaceutical injection to relieve bone pain in patients with painful skeletal metastases. In the body, Strontium acts similar to calcium and is preferentially taken up in osteoblastic tissue while the unabsorbed isotope is excreted in the urine the first 2 to 3 days following injection, clearing rapidly from the blood and selectively localizing in bone mineral. Uptake of strontium by bone occurs preferentially in sites of active osteogenesis; thus primary bone tumors and areas of metastatic involvement (blastic lesions) can accumulate significa...